Mutations identified in humans with ameloblastomas have affected genes of the MAPK pathway; specifically, BRAFV600E mutations are predominantly in mandibular ameloblastoma while SMO mutations are mostly found in maxillary tumors (22). The gene discussed is SMO; the disease is ameloblastoma.